Analyst Recommendations

Citigroup analyst issues NEUTRAL recommendation for MPLX on February 10, 2026 11:27AM ET. The previous analyst recommendation was Neutral.MPLX was trading at $55.01 at issue of the analyst...

February 10, 2026   MPLX 2.90%

Piper Sandler analyst issues NEUTRAL recommendation for MGY on February 10, 2026 11:26AM ET. The previous analyst recommendation was Neutral.MGY was trading at $27.27 at issue of the...

February 10, 2026   MGY 2.98%

Wells Fargo analyst issues OVERWEIGHT recommendation for EPC on February 10, 2026 11:33AM ET. The previous analyst recommendation was Overweight.EPC was trading at $19.79 at issue of the...

February 10, 2026   EPC 2.34%

Wells Fargo analyst issues OVERWEIGHT recommendation for COR on February 10, 2026 11:35AM ET. The previous analyst recommendation was Overweight.COR was trading at $363.27 at issue of the...

February 10, 2026   COR 2.73%

Wells Fargo analyst issues OVERWEIGHT recommendation for WMT on February 10, 2026 11:32AM ET. The previous analyst recommendation was Overweight.WMT was trading at $129.02 at issue of the...

February 10, 2026   WMT 0.18%

Wells Fargo analyst issues OVERWEIGHT recommendation for CAH on February 10, 2026 11:36AM ET. The previous analyst recommendation was Overweight.CAH was trading at $225.76 at issue of the...

February 10, 2026   CAH 2.46%

Citigroup analyst issues BUY recommendation for ROST on February 10, 2026 11:33AM ET. The previous analyst recommendation was Buy.ROST was trading at $194.5 at issue of the analyst...

February 10, 2026   ROST 0.87%

Citigroup analyst issues BUY recommendation for ROIV on February 10, 2026 11:32AM ET. The previous analyst recommendation was Buy.ROIV was trading at $27.67 at issue of the analyst...

February 10, 2026   ROIV -1.33%

Wells Fargo analyst issues OVERWEIGHT recommendation for ON on February 10, 2026 11:37AM ET. The previous analyst recommendation was Overweight.ON was trading at $65.1 at issue of the...

February 10, 2026   ON 1.46%

Exane BNP Paribas analyst issues OUTPERFORM recommendation for BIOVF on February 10, 2026 09:58AM ET. BIOVF was trading at $37 at issue of the analyst recommendation.The overall analyst...

February 10, 2026   ON 1.46%